Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/28/2022* -- Results Q3 2022 -- 2.24 --
10/28/2022* 16:30 EST Earnings Call Q3 2022 -- -- --
07/26/2022 -- Results Q2 2022 2.25 2.28 -1.51%
07/26/2022 16:30 EST Earnings Call Q2 2022 -- -- --
04/28/2022 -- Results Q1 2022 1.97 1.94 1.56%
04/28/2022 16:30 EST Earnings Call Q1 2022 -- -- --
01/27/2022 16:30 EST Earnings Call Q4 2021 -- -- --
01/27/2022 -- Results Q4 2021 2.71 2.72 -0.45%
*Estimated Date/Time

Earnings

Next Report Date 10/28/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/26/2022
Beat/Miss Upgrade
Return Since 3.00%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States.
URL https://www.stryker.com
Investor Relations URL https://investors.stryker.com
HQ State/Province Michigan
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Jul. 26, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 29, 2022

Dividends

Dividend Per Share (TTM) 2.715
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.9019
Yield to Sector 0.7179
Yield to Industry 0.745
Last Dividend Amt. 0.695
Dividend Frequency Quarterly
Last Ex-Dividend Date Sep. 29, 2022
Yield (TTM) 1.29%
Forward Yield 1.32%
Payout Ratio 48.10%
Cash Payout Ratio 48.38%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
0.01%
30.68%
30.84%
2.43%
35.33%
18.15%
10.22%
-20.79%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.90%
1.89%
-12.32%
52.00%
29.04%
22.10%
28.00%
30.54%
-28.44%
137.2%
24.81%
66.32%
73.44%
-47.52%
90.05%
10.79%
-28.96%
--
--
--
--
--
136.2%
71.93%
56.43%
-0.84%
17.58%
47.29%
2.89%
28.39%
-2.94%
8.45%
-34.40%
As of October 03, 2022.

Profile

Edit
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States.
URL https://www.stryker.com
Investor Relations URL https://investors.stryker.com
HQ State/Province Michigan
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Jul. 26, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 29, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
HHL.TO 52.96M USD 4.86%
IHI 275.76M USD 4.67%
JENRX 401.17M USD 4.12%
FRDRX 687.93M USD 2.83%
VDIGX 1.262B USD 2.51%
VGHCX 1.016B USD 2.24%
IYH 45.06M USD 1.50%
XLV 550.74M USD 1.49%
FHLC 36.09M USD 1.28%
VHT 237.12M USD 1.28%
RRGSX 449.06M USD 0.96%
TRZBX 490.50M USD 0.78%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter SYK Tweets